Table 4.
The role of Tripterygium ingredients for DCs.
| Component | Models | Molecular mechanism | Effects | Animal disease phenotype | Ref. |
|---|---|---|---|---|---|
| Duantengyimu decoction | GM-CSF and IL-4 stimulate PBMCs isolated from patients with RA | NA | Decrease the expression of CCR5 and CCR7, decrease the secretion of CXCL9 and CXCL10, and inhibit the migration of DC | NA | (Sun, 2017) |
| Tripterygium Wilfordii Saponins | GM-CSF, TNF-α, and IL-4 stimulate PBMCs | NA | Inhibit the expressions HLA-DR and CD80 on the membrane. Decrease the synthesis of IL-12 p40 subunit | NA | (Wang et al., 2001) |
| Tripterygium glycosides | DCs isolated from rats | NA | Reduce the expression of MHC-II, CD80, CD86, and CD40 on the membrane of DC | NA | (Chen et al., 2006) |
TP, Triptolide; Caspase, Aspartic acid protease containing cysteine; CCR, Chemokine receptor; CXCL, C-X-C motif chemokine ligand; MAP, Mitogen activated protein; MHC, Major histocompatibility complex.